6KapLan A P. ALLergy[M]. New York: ChurchiLL Livingston, 1985: 688.
7PassaLacquag ALbano M, Riccio Am, et al. Local nasal immanotherapy. ExperimentaL evidences and general considerations[J]. ALLergy, 1997, 52: 10.
8R. PoLosa, F LiGotti, G M angano, et al. Effect of immunotherapy on asthma progression, BHR and sputum eosinophiLs in aLLergic rhinitis [ J ]. ALLergy, 2004, 59 : 1224.
9PAJNO G B, BARBERIO G, Fr DE LUCA, et al. Prevention of new sensitizations in asthmatic chiL - dren monosensitized to house dustm ire by specific immunotherapy: A six - year foLLow- up study[J]. CLinicaL and ExperimentaL ALLergy, 2001(31):1392.
5Bousquet J,Van Cauwenberge P,Khaltaev N,et al.Allergic thinitis and its inpact on asthma[J].J A llergy Clin immunol,2001,108(5):S147-334.
6Skoner DP,Doyle WJ,Boehm S,et al.Effect of terfenadine on nasal,eustachian tube,and pulmonary function after provocative intranasal histamine challenge[J].Ann Allergy,1991,67(6):619-624.
7[1]Bousquet J,Lockey R,Mailing HJ.Allergen immunotherapy:therapeutic vaccines for allergic diseases.A WHO position paper.J Allergy Clin Immunol,1998,102:558-562.
8[2]Bousquet J,Van Cauwenberge P,Khaltaev N.Allergic rhinitis and its impact on asthma.J Allergy Clin Immunol,2001,108:147-334.
9[3]Olsen OT,Larsen KR,Jacobsan L,et al.A 1-year,placebocontrolled,double-blind house-dust-mite immunotherapy study in asthmatic adults.Allergy,1997,52:853-859.
10[4]Alvarez-Cuesta E,Bousquet J,Canonica GW,et al.Standards for practical allergen-specific immunotherapy.Allergy,2006,61:1-20.
9Passalacqua G, Durham SR, Global Allergy and Asthma European Network. Allergic rhinitis and its Impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol, 2007, 119 (4) : 881-891.
10Cox L. Accelerated immunotherapy schedules: review of efficacy and safety. Ann Allergy Asthma Immunol, 2006, 97 (2) : 126-137.
